Stocks · Health care · Pharmaceutical Preparations

Aquestive Therapeutics, Inc.

AQST Clue Score18
United States Fiscal year ends December CIK 0001398733 Results filed 3 Nov 2026

What the insiders did Balanced

Insider
Date
Role
Action
Shares
Price
Amount
Daniel Barber
15 Oct 2026
President and CEO
Sold on a plan
25,000
$4.22
$105.60K
Daniel Barber
15 Sep 2026
President and CEO
Sold on a plan
25,000
$4.82
$120.49K
Sherry Korczynski
9 Sep 2026
Chief Commercial Officer
Sold after exercise
8,750
$5.22
$45.68K
Peter E. Boyd
9 Sep 2026
Chief People Officer
Exercised, kept
2,293
$0.96
$2.20K
Daniel Barber
8 Sep 2026
President and CEO
Exercised, kept
91,743
$0.96
$88.07K
Cassie Jung
3 Sep 2026
Chief Operating Officer
Exercised, kept
4,587
$0.96
$4.40K
Daniel Barber
17 Aug 2026
President and CEO
Sold on a plan
25,000
$4.29
$107.17K
Daniel Barber
16 Jul 2026
President and CEO
Sold on a plan
20,369
$4.00
$81.51K
Daniel Barber
15 Jul 2026
President and CEO
Sold on a plan
4,631
$4.03
$18.68K
Julie Krop
23 Jun 2026
Director
Sold after exercise
25,000
$5.02
$125.39K
Daniel Barber
15 Jun 2026
President and CEO
Sold on a plan
25,000
$4.16
$104.01K
Daniel Barber
15 May 2026
President and CEO
Sold on a plan
8,257
$4.29
$35.41K
Cassie Jung
10 Mar 2026
Chief Operating Officer
Sell
45,791
$4.17
$191.09K
Sherry Korczynski
10 Mar 2026
Chief Commercial Officer
Sell
15,741
$4.17
$65.69K
A Ernest Toth Jr
10 Mar 2026
Chief Financial Officer
Sell
58,254
$4.17
$243.09K
Melina Cioffi
10 Mar 2026
SVP, Regulatory Affairs
Sell
25,311
$4.17
$105.62K
Lori J Braender
10 Mar 2026
Chief Legal Officer
Sell
40,102
$4.17
$167.35K
Daniel Barber
10 Mar 2026
President and CEO
Sell
180,677
$4.17
$753.97K
Peter E. Boyd
10 Mar 2026
Chief People Officer
Sell
29,814
$4.17
$124.41K
Peter E. Boyd
15 Oct 2025
See Remarks
Sold on a plan
10,000
$7.00
$70.00K
Carl N Kraus
15 Oct 2025
Chief Medical Officer
Sold on a plan
20,272
$7.00
$141.90K
Cassie Jung
15 Oct 2025
Chief Operating Officer
Sold after exercise
67,575
$7.01
$473.70K
Peter E. Boyd
26 Sep 2025
See Remarks
Sold on a plan
10,000
$6.30
$63.00K
Daniel Barber
26 Sep 2025
President and CEO
Sold on a plan
91,343
$6.03
$551.19K
Daniel Barber
19 Sep 2025
President and CEO
Sold on a plan
400
$6.00
$2.40K
Peter E. Boyd
5 Sep 2025
See Remarks
Sold on a plan
15,000
$5.30
$79.50K
Cassie Jung
4 Sep 2025
Chief Operating Officer
Sold after exercise
62,180
$5.00
$310.90K
Cassie Jung
26 Nov 2024
Chief Operating Officer
Sell indirect
44
$4.87
$214.06
Alexander Mark Schobel
15 Mar 2024
Chief Innovation/Tech Officer
Sold on a plan
50,000
$6.00
$300.00K
Alexander Mark Schobel
8 Mar 2024
Chief Innovation/Tech Officer
Sold on a plan
25,000
$5.19
$129.69K
Peter E. Boyd
14 Jun 2022
SVP-Bus. Process & Info. Tech.
Buy
5,000
$0.81
$4.05K
Lori J Braender
8 Jun 2022
General Counsel
Buy
13,761
$0.96
$13.21K
Peter E. Boyd
8 Jun 2022
SVP-Bus. Process & Info. Tech.
Buy
2,293
$0.96
$2.20K
Alexander Mark Schobel
8 Jun 2022
Chief Innovation/Tech Officer
Buy
45,871
$0.96
$44.04K
Daniel Barber
8 Jun 2022
Chief Executive Officer
Buy
91,743
$0.96
$88.07K
Alexander Mark Schobel
10 Feb 2021
Chief Innovation/Tech Officer
Sell
23,460
$6.75
$158.36K
Alexander Mark Schobel
9 Feb 2021
Chief Innovation/Tech Officer
Sell
11,540
$6.75
$77.90K
Alexander Mark Schobel
8 Feb 2021
Chief Innovation/Tech Officer
Sell
40,792
$6.50
$265.15K
John T. Maxwell
18 Aug 2020
SVP-Chief Financial Officer
Sell
3,000
$8.00
$24.00K
Keith J Kendall
4 Jun 2020
CEO and President
Sell
50,000
$5.11
$255.31K
Alexander Mark Schobel
8 May 2020
Chief Innovation/Tech Officer
Sell
40,000
$5.00
$200.00K
Alexander Mark Schobel
29 Apr 2020
Chief Innovation/Tech Officer
Sell
40,000
$4.50
$180.00K
Alexander Mark Schobel
27 Apr 2020
Chief Innovation/Tech Officer
Sell
40,000
$4.00
$160.00K
Alexander Mark Schobel
14 Apr 2020
Chief Innovation/Tech Officer
Sell
40,000
$3.70
$148.00K
Peter E. Boyd
16 Mar 2020
SVP-Bus. Process & Info. Tech.
Buy
2,000
$1.50
$3.00K
Lori J Braender
16 Mar 2020
SVP, General Counsel
Buy
14,000
$1.54
$21.62K
Daniel Barber
27 Aug 2019
SVP-Chief Operating Officer
Buy
2,000
$3.99
$7.98K
James S Scibetta
21 Aug 2019
Director
Buy
900
$3.81
$3.43K
James S Scibetta
20 Aug 2019
Director
Buy
11,310
$3.80
$43.00K
James S Scibetta
19 Aug 2019
Director
Buy
10,761
$3.77
$40.55K
Keith J Kendall
14 Aug 2019
CEO and President
Buy
1,000
$3.65
$3.65K
Keith J Kendall
14 Aug 2019
CEO and President
Buy
1,000
$3.70
$3.70K
Keith J Kendall
13 Aug 2019
CEO and President
Buy
1,000
$4.05
$4.05K
Peter E. Boyd
12 Aug 2019
SVP-Bus. Process & Info. Tech.
Buy
600
$3.81
$2.29K
Lori J Braender
9 Aug 2019
SVP, General Counsel
Buy
10,000
$4.07
$40.75K
Theresa Wood
9 Aug 2019
SVP-HR and Org. Development
Buy
1,000
$3.99
$3.99K
Keith J Kendall
9 Aug 2019
CEO and President
Buy
2,000
$4.00
$7.99K
Keith J Kendall
9 Aug 2019
CEO and President
Buy
1,000
$3.93
$3.93K
Keith J Kendall
9 Aug 2019
CEO and President
Buy
2,000
$3.84
$7.68K
Daniel Barber
10 Dec 2018
SVP-Chief Strategy/Dev Officer
Buy
1,000
$8.00
$8.00K
Alexander Mark Schobel
10 Dec 2018
Chief Innovation/Tech Officer
Buy
1,000
$7.78
$7.78K
John T. Maxwell
6 Dec 2018
SVP-Chief Financial Officer
Buy
5,000
$8.87
$44.35K
Alexander Mark Schobel
6 Dec 2018
Chief Innovation/Tech Officer
Buy
2,000
$8.69
$17.38K
Keith J Kendall
27 Nov 2018
CEO and President
Buy
1,000
$9.87
$9.87K
Lori J Braender
27 Nov 2018
General Counsel
Buy
1,000
$10.57
$10.57K
Theresa Wood
26 Nov 2018
SVP-HR and Org. Development
Buy
500
$10.34
$5.17K
Keith J Kendall
23 Nov 2018
CEO and President
Buy
1,950
$9.90
$19.31K
Keith J Kendall
21 Nov 2018
CEO and President
Buy
6,000
$10.17
$61.02K
Peter E. Boyd
21 Nov 2018
SVP-Operations/Value Delivery
Buy
200
$9.98
$2.00K
John T. Maxwell
21 Nov 2018
SVP-Chief Financial Officer
Buy
10,000
$9.80
$98.00K
Alexander Mark Schobel
21 Nov 2018
Chief Innovation/Tech Officer
Buy
1,000
$10.25
$10.25K
Ken W. Marshall
21 Nov 2018
Commercial Leader
Buy indirect
1,445
$10.15
$14.67K
Douglas K Bratton
24 Jul 2018
Director
Buy indirect
165,000
$15.00
$2.48M

What was left out

Form 4 filings counted 284
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 4
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 11,746,136
Sales filed before the plan box existed 9
History held since 26 Jul 2018